Approaches to Demonstrate Similarity

Biosimilars must be demonstrated to be similar to the original biologic agent, meaning side-by-side characterisation studies are required to assess if similarity can be achieved and to demonstrate proof for regulatory agencies. In this article, our expert discusses the challenges and analytical approaches required to demonstrate similarity.

Complete the form below to download the article.